What is Beam Therapeutics's net margin?

Beam Therapeutics (BEAM) reported net margin of -742.7% in Q3 2025.

What is the long-term trend for Beam Therapeutics's net margin?

Over 3 years (2020 to 2024), Beam Therapeutics's net margin has grown at a -91.0% compound annual growth rate (CAGR), from -810,800% to -593.1%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Beam Therapeutics BEAM Net margin

Net margin at other companies

Vertex PharmaceuticalsVRTX

35.5%—

Arrowhead ResearchARWR

-48.4%+240pp

CRISPR TherapeuticsCRSP

-13,856.5%-15,058pp

PTC TherapeuticsPTCT

42.3%+27.4pp

BridgeBio PharmaBBIO

-125.9%-54.5pp

Protagonist TherapeuticsPTGX

-154.9%-182pp

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.51B+24.5%

Enterprise value$3.47B+51.2%

P/S21.4×-23.0×

Profitability

See full

Operating margin-226.6%-90.5pp

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Calculated from Beam Therapeutics’s reported figures.

net income/total revenue=-742.7%

Based on trailing twelve months.

The official record: Beam Therapeutics’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's net margin?: Beam Therapeutics (BEAM) reported net margin of -742.7% in Q3 2025.
What is the long-term trend for Beam Therapeutics's net margin?: Over 3 years (2020 to 2024), Beam Therapeutics's net margin has grown at a -91.0% compound annual growth rate (CAGR), from -810,800% to -593.1%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.